A carregar...
Differences in survival of patients with recurrent versus de novo metastatic KRAS and EGFR mutant lung cancers
BACKGROUND: Prognostic variables are independently associated with survival and are fundamental to clinical trial design. We evaluated the impact of stage at initial diagnosis on overall survival in two independent, oncogene-defined cohorts. METHODS: All patients with EGFR-mutant and KRAS-mutant met...
Na minha lista:
| Publicado no: | Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4783794/ https://ncbi.nlm.nih.gov/pubmed/25781862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29313 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|